CMCSA vs CVS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 09, 2026
CMCSA
CVS
Investment Advisor Scores
CVS
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CMCSA | CVS | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 6.8966 | 14.1643 | CMCSA |
| PEG Ratio | 2.39 | 0.294 | CVS |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -1.2% | 7.1% | CVS |
| Earnings Growth | -66.8% | 188.8% | CVS |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 35.1/100 | 44.5/100 | CVS |
| Profit Margin | 9.0% | 1.2% | CMCSA |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | SELL | HOLD | CVS |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CMCSA
NeutralMixed signals - no dominant trend phase, RSI 63
CVS
NeutralMixed signals - no dominant trend phase, RSI 29
Fundamentals Snapshot
| Metric | CMCSA | CVS |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 7.1 | 11.0 |
| Trailing P/E | 8.1 | 25.2 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.1% |
| Gross Margin | 0.7% | 0.1% |
| Operating Margin | 0.2% | 0.0% |
| EPS | 3.10 | 3.79 |
| Dividend Yield | 0.05% | 0.03% |